Department of Community Medicine, UiT The Arctic University of Norway Faculty of Health Sciences, Tromso, Norway
Centre for Clinical Documentation and Evaluation (SKDE), Northern Norway Regional Health Authority, Bodo, Norway.
BMJ Open. 2024 Feb 17;14(2):e081301. doi: 10.1136/bmjopen-2023-081301.
This study aimed to investigate determinants of reperfusion within recommended time limits (timely reperfusion) for ST-segment elevation myocardial infarction patients, exploring the impact of geography, patient characteristics and socio-economy.
National register-based cohort study.
Multilevel logistic regression models were applied to examine the associations between timely reperfusion and residency in hospital referral areas and municipalities, patient characteristics, and socio-economy.
7607 Norwegian ST-segment elevation myocardial infarction patients registered in the Norwegian Registry of Myocardial Infarction during 2015-2018.
The odds of timely reperfusion by primary percutaneous coronary intervention (PCI) or fibrinolysis.
Among 7607 ST-segment elevation myocardial infarction patients in Norway, 56% received timely reperfusion. The Norwegian goal is 85%. While 81% of the patients living in the Oslo hospital referral area received timely reperfusion, only 13% of the patients living in Finnmark did so.Patients aged 75-84 years had lower odds of timely reperfusion than patients below 55 years of age (OR 0.73, 95% CI 0.61 to 0.87). Patients with moderate or high comorbidity had lower odds than patients without (OR 0.81, 95% CI 0.68 to 0.95 and OR 0.61, 95% CI 0.44 to 0.84). More than 2 hours from symptom onset to first medical contact gave lower odds than less than 30 min (OR 0.63, 95% CI 0.54 to 0.72). 1-2 hours of travel time to a PCI centre (OR 0.39, 95% CI 0.31 to 0.49) and more than 2 hours (OR 0.22, 95% CI 0.16 to 0.30) gave substantially lower odds than less than 1 hour of travel time.
The varying proportion of patients receiving timely reperfusion across hospital referral areas implies inequity in fundamental healthcare services, not compatible with established Norwegian health policy. The importance of travel time to PCI centre points at the expanded use of prehospital pharmacoinvasive strategy to obtain the goals of timely reperfusion in Norway.
本研究旨在探讨 ST 段抬高型心肌梗死患者在推荐时间内(及时再灌注)再灌注的决定因素,探讨地理、患者特征和社会经济因素的影响。
全国注册队列研究。
应用多水平逻辑回归模型来研究及时再灌注与医院转诊区和自治市、患者特征和社会经济之间的关系。
2015 年至 2018 年期间在挪威心肌梗死登记处登记的 7607 名挪威 ST 段抬高型心肌梗死患者。
通过直接经皮冠状动脉介入治疗(PCI)或溶栓获得及时再灌注的可能性。
在挪威的 7607 例 ST 段抬高型心肌梗死患者中,56%接受了及时再灌注。挪威的目标是 85%。虽然居住在奥斯陆医院转诊区的 81%的患者接受了及时再灌注,但只有 13%居住在芬马克的患者接受了及时再灌注。75-84 岁的患者及时再灌注的可能性低于 55 岁以下的患者(OR 0.73,95%CI 0.61-0.87)。有中度或高度合并症的患者比没有合并症的患者及时再灌注的可能性较低(OR 0.81,95%CI 0.68-0.95 和 OR 0.61,95%CI 0.44-0.84)。从症状发作到首次医疗接触超过 2 小时的患者比少于 30 分钟的患者获得及时再灌注的可能性较低(OR 0.63,95%CI 0.54-0.72)。前往 PCI 中心的旅行时间为 1-2 小时(OR 0.39,95%CI 0.31-0.49)和超过 2 小时(OR 0.22,95%CI 0.16-0.30)的患者获得及时再灌注的可能性明显低于旅行时间少于 1 小时的患者。
医院转诊区接受及时再灌注的患者比例不同,这意味着基本医疗服务存在不公平现象,不符合挪威既定的卫生政策。前往 PCI 中心的旅行时间的重要性表明,需要扩大使用院前药物侵入性策略,以实现挪威及时再灌注的目标。